FBXO45 and non-small cell lung carcinoma: To further verify the possibility of Fbxo45 affecting the STEP activity, knockdown Fbxo45 significantly enhanced the NP‐STEP level and correspondingly inhibited ERK activity in all four NSCLC cell lines (Fig. 3E).